Peter was diagnosed with cancer at the age of 12. Under pressure to deliver fast help, researchers in Heidelberg searched for a drug for him - with the help of mini-tumours grown in the laboratory.

Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit percentage this year, helped by lower costs and growth from drugs such as eye ...

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.

Mayo Clinic's organoids, microscopic versions of organs that function like the real ones, have been used by doctors to study ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

Princess Kate could feature on the cover of Vogue as the editor-in-chief Anna Wintour is said to be eyeing up the Queen in ...

Now aged two, Flynn, from Wigston in Leicestershire, went through months of chemotherapy and laser therapy to treat a rare ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this ...

Seattle doctors developed a blood test that determines the parental origin of the RB1 mutation in retinoblastoma.

The Traitors finished in dramatic fashion on Friday evening with Leanne Quigley and Jake Brown taking home the grand prize ...

Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the US Patent Office (USPTO) has granted Active Biotech's US patent application 17/939,109 for laquinimod in eye disorders. "We ...